Tempus AI, Inc. (NASDAQ:TEM) Receives $61.18 Average PT from Brokerages

Tempus AI, Inc. (NASDAQ:TEM - Get Free Report) has received a consensus rating of "Moderate Buy" from the twelve ratings firms that are currently covering the stock, MarketBeat.com reports. Six analysts have rated the stock with a hold rating and six have given a buy rating to the company. The average 12 month target price among analysts that have issued a report on the stock in the last year is $61.18.

TEM has been the subject of a number of recent analyst reports. Bank of America boosted their price target on shares of Tempus AI from $54.00 to $60.00 and gave the company a "neutral" rating in a research report on Monday, March 3rd. JPMorgan Chase & Co. cut Tempus AI from an "overweight" rating to a "neutral" rating and raised their price target for the company from $50.00 to $55.00 in a report on Tuesday, February 25th. Wolfe Research cut shares of Tempus AI from a "strong-buy" rating to a "hold" rating in a research report on Wednesday, February 26th. Guggenheim reaffirmed a "buy" rating on shares of Tempus AI in a research note on Tuesday, February 25th. Finally, TD Cowen reissued a "buy" rating and issued a $74.00 price target (up previously from $58.00) on shares of Tempus AI in a report on Wednesday, February 5th.

Tempus AI Trading Up 6.5 %

Shares of TEM traded up $2.97 during midday trading on Friday, hitting $48.71. 8,386,707 shares of the company traded hands, compared to its average volume of 5,002,730. The stock has a 50-day moving average of $55.65 and a 200-day moving average of $51.50. Tempus AI has a one year low of $22.89 and a one year high of $91.45. The company has a current ratio of 2.69, a quick ratio of 2.55 and a debt-to-equity ratio of 8.17.

Remove Ads

Insider Activity

In other Tempus AI news, Director Jennifer A. Doudna sold 1,320 shares of Tempus AI stock in a transaction that occurred on Friday, February 14th. The shares were sold at an average price of $90.00, for a total transaction of $118,800.00. Following the transaction, the director now owns 36,011 shares of the company's stock, valued at $3,240,990. The trade was a 3.54 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Eric P. Lefkofsky sold 562,345 shares of the company's stock in a transaction dated Wednesday, March 5th. The stock was sold at an average price of $50.93, for a total value of $28,640,230.85. Following the completion of the transaction, the chief executive officer now directly owns 9,457,283 shares of the company's stock, valued at approximately $481,659,423.19. This trade represents a 5.61 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 5,561,814 shares of company stock worth $315,485,164 in the last quarter.

Institutional Investors Weigh In On Tempus AI

Several institutional investors have recently modified their holdings of TEM. Wells Fargo & Company MN lifted its stake in shares of Tempus AI by 13.2% during the 4th quarter. Wells Fargo & Company MN now owns 2,384 shares of the company's stock worth $80,000 after acquiring an additional 278 shares during the last quarter. First Horizon Advisors Inc. purchased a new stake in shares of Tempus AI during the third quarter worth about $30,000. Geode Capital Management LLC boosted its position in Tempus AI by 0.4% in the third quarter. Geode Capital Management LLC now owns 133,171 shares of the company's stock valued at $7,537,000 after buying an additional 539 shares during the last quarter. Operose Advisors LLC purchased a new position in shares of Tempus AI during the 4th quarter valued at approximately $25,000. Finally, Prestige Wealth Management Group LLC boosted its stake in Tempus AI by 910.4% during the 4th quarter. Prestige Wealth Management Group LLC now owns 1,071 shares of the company's stock worth $36,000 after purchasing an additional 965 shares during the last quarter. 24.22% of the stock is owned by institutional investors.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.